Search Within

Ayana Sawai

Formats
  1. Meeting Abstract (9)
  2. Journal Article (8)
Groups
  1. Breast Medicine Service (17)
  2. Department of Medicine (17)
  3. GSK Faculty (17)
  4. Human Oncology and Pathogenesis Program (17)
  5. Molecular Pharmacology and Chemistry Program Faculty (17)
  6. Sloan Kettering Institute Faculty (17)

More Groups

People
  1. Neal Rosen (17)
  2. David Solit (15)
  3. Christine Pratilas (9)
  4. Olivera Grbovic-Huezo (7)
  5. Qing Ye (6)
  6. Andrea Basso (5)

More People

Years
  1. 2011 (2)
  2. 2008 (3)
  3. 2007 (4)
  4. 2006 (4)
  5. 2005 (2)
  6. 2004 (1)

More Years

Publications
  1. Cancer Research (8)
  2. Clinical Cancer Research (2)
  3. Cancer Cell (1)
  4. EJC Supplements (1)
  5. Journal of Clinical Oncology (1)
  6. Molecular Cancer Therapeutics (1)

More Publications

Publishers
  1. American Association for Cancer Research (11)
  2. American Society of Clinical Oncology (1)
  3. Cell Press (1)
  4. National Academy of Sciences (1)
  5. Nature Publishing Group (1)
  6. Pergamon-Elsevier Science Ltd (1)

More Publishers

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association with HSP90 inhibits Cbl-mediated down-regulation of mutant epidermal growth factor receptors
    Journal Article

    Yang, S.; Qu, S.; Perez-Tores, M.; Sawai, A.; Rosen, N.; Solit, D. B.; Arteaga, C. L.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • BRAF mutation predicts sensitivity to MEK inhibition
    Journal Article

    Solit, D. B.; Garraway, L. A.; Pratilas, C. A.; Sawai, A.; Getz, G.; Basso, A.; Ye, Q.; Lobo, J. M.; She, Y.; Osman, I.; more...
    Nature (2006)

    Fulltext@MSK | Save
  • V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors
    Journal Article

    Grbovic, O. M.; Basso, A. D.; Sawai, A.; Ye, Q.; Friedlander, P.; Solit, D.; Rosen, N.
    Proceedings of the National Academy of Sciences of the United States of America (2006)

    Fulltext@MSK | Save
  • Cyclin D expression and G1 progression are dependent on MEK MAP kinase activity in tumor cells with B-Raf mutation but not in breast cancer cells with wild type Ras and Raf
    Meeting Abstract

    Sawai, A.; Pratilas, C.; Basso, A.; Rosen, N.; Solit, D. B.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • The MEK inhibitor PD0325901 completely inhibits the growth of melanoma tumors with mutationally activated B-Raf
    Meeting Abstract

    Pratilas, C.; Sawai, A.; Ye, Q.; Lobo, J.; She, Y.; Sebolt-Leopold, J.; Rosen, N.; Solit, D.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • Cyclin D expression and G1 progression are dependent on MEK-MAP kinase activity in tumor cells with B-Raf mutation but not in breast cancer cells with wild type Ras and Raf
    Meeting Abstract

    Pratilas, C. A.; Grbovic, O.; Basso, A. D.; Sawai, A.; Chapman, P.; Rosen, N.; Solit, D. B.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Cyclin D expression and G1 progression are dependent on MEK-MAP kinase activity in tumor cells with B-Raf mutation but not in breast cancer cells with wild type Ras
    Meeting Abstract

    Sawai, A.; Basso, A. D.; Solit, D. B.; She, Q. B.; Grbovic, O.; Pratilas, C.; Chapman, P.; Moasser, M. M.; Rosen, N.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save